| # | Title | Journal | Year | Citations |
|---|
| 1 | Consensus statement on the pathology of IgG4-related disease | Modern Pathology | 2012 | 2,171 |
| 2 | Prognostic and predictive factors in breast cancer by immunohistochemical analysis | Modern Pathology | 1998 | 1,480 |
| 3 | Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma | Modern Pathology | 2006 | 932 |
| 4 | Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases | Modern Pathology | 2000 | 916 |
| 5 | Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases | Modern Pathology | 2011 | 866 |
| 6 | Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies | Modern Pathology | 2020 | 762 |
| 7 | A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal | Modern Pathology | 2018 | 739 |
| 8 | Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 | Modern Pathology | 2017 | 652 |
| 9 | Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics | Modern Pathology | 2014 | 585 |
| 10 | Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology | 2002 | 571 |
| 11 | ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor | Modern Pathology | 2001 | 550 |
| 12 | Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Modern Pathology | 2011 | 545 |
| 13 | CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34 | Modern Pathology | 1998 | 532 |
| 14 | Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT) | Modern Pathology | 2000 | 530 |
| 15 | Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors | Modern Pathology | 1997 | 494 |
| 16 | HER2 testing in gastric cancer: a practical approach | Modern Pathology | 2012 | 478 |
| 17 | Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues | Modern Pathology | 2005 | 477 |
| 18 | The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine | Modern Pathology | 2013 | 449 |
| 19 | Extragastrointestinal (Soft Tissue) Stromal Tumors: An Analysis of 48 Cases with Emphasis on Histologic Predictors of Outcome | Modern Pathology | 2000 | 447 |
| 20 | Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach | Modern Pathology | 2000 | 437 |
| 21 | EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset | Modern Pathology | 2009 | 429 |
| 22 | Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis | Modern Pathology | 2011 | 417 |
| 23 | The histopathology of fatal untreated human respiratory syncytial virus infection | Modern Pathology | 2007 | 414 |
| 24 | Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model | Modern Pathology | 2012 | 403 |
| 25 | Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients | Modern Pathology | 2010 | 396 |
| 26 | Gleason grading and prognostic factors in carcinoma of the prostate | Modern Pathology | 2004 | 388 |
| 27 | COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City | Modern Pathology | 2020 | 380 |
| 28 | A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression | Modern Pathology | 2020 | 378 |
| 29 | NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls | Modern Pathology | 2020 | 373 |
| 30 | Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray | Modern Pathology | 2003 | 363 |
| 31 | Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis | Modern Pathology | 2008 | 363 |
| 32 | Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 Cases | Modern Pathology | 2002 | 360 |
| 33 | Basal cell carcinoma: biology, morphology and clinical implications | Modern Pathology | 2006 | 360 |
| 34 | Molecular characterization of cancers with NTRK gene fusions | Modern Pathology | 2019 | 360 |
| 35 | Comprehensive analysis of HE4 expression in normal and malignant human tissues | Modern Pathology | 2006 | 354 |
| 36 | Origins and molecular pathology of ovarian cancer | Modern Pathology | 2005 | 344 |
| 37 | Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation | Modern Pathology | 2010 | 344 |
| 38 | p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Modern Pathology | 2012 | 343 |
| 39 | Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative | Modern Pathology | 2015 | 343 |
| 40 | Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas | Modern Pathology | 2016 | 340 |
| 41 | Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors | Modern Pathology | 2000 | 338 |
| 42 | Pulmonary pathology of severe acute respiratory syndrome in Toronto | Modern Pathology | 2005 | 331 |
| 43 | Thyroid carcinoma: molecular pathways and therapeutic targets | Modern Pathology | 2008 | 331 |
| 44 | Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns | Modern Pathology | 2010 | 325 |
| 45 | Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms | Modern Pathology | 2011 | 325 |
| 46 | Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications | Modern Pathology | 2009 | 324 |
| 47 | Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine | Modern Pathology | 2018 | 324 |
| 48 | Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features | Modern Pathology | 2003 | 323 |
| 49 | Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles | Modern Pathology | 2005 | 322 |
| 50 | β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation | Modern Pathology | 2011 | 319 |
